Serine protease inhibitors

Abstract

Compounds of formula (I) in which R 2 , X, Y, Cy, L and Lp(D) n have the meanings given in the specification, are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders.

1 . A serine protease inhibitor compound of formula (I)  
       
         
           
           
               
               
           
         
       
       wherein: 
 R 2  is a 5 or 6 membered aromatic carbon ring optionally interrupted by a nitrogen, oxygen or sulphur ring atom, optionally being substituted in the 3 and/or 4 position (in relation to the point of attachment of X—X) by halo, nitro, thiol, haloalkoxy, hydrazido, alkylhydrazido, amino, cyano, haloalkyl, alkylthio, alkenyl, alkynyl, acylamino, tri or difluoromethoxy, carboxy, acyloxy, MeSO 2 — or R 1 , or the substituents at the 3 and 4 positions taken together form a fused ring which is a 5 or 6 membered carbocyclic or heterocyclic ring optionally substituted by halo, haloalkoxy, haloalkyl, cyano, nitro, amino, hydrazido, alkylthio, alkenyl, alkynyl or R 1j , and optionally substituted in the position alpha to the X—X group (i.e. 6 position for a six membered aromatic ring etc) by amino, hydroxy, halo, alkyl, carboxy, alkoxycarbonyl, cyano, amido, aminoalkyl, alkoxy or alkylthio with the proviso that R 2  cannot be aminoisoquinolyl;  
 each X independently is a C, N, O or S atom or a CO, CR 1a , C(R 1a ) 2  or NR 1a  group, at least one X being C, CO, CR 1a  or C(R 1a ) 2 ;  
 each R 1a  independently represents hydrogen, hydroxyl, alkoxy, alkyl, aminoalkyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, alkylaminocarbonyl, alkoxycarbonylamino, acyloxymethoxycarbonyl or alkylamino optionally substituted by hydroxy, alkylamino, alkoxy, oxo, aryl or cycloalkyl;  
 R 1  is as defined for R 1a , provided that R 1  is not unsubstituted aminoalkyl;  
 Y (the α-atom) is a nitrogen atom or a CR 1b  group;  
 Cy is a saturated or unsaturated, mono or poly cyclic, homo or heterocyclic group, optionally substituted by groups R 3a  or R 3i X i ;  
 each R 3a  independently is R 1c , amino, halo, cyano, nitro, thiol, alkylthio, alkylsulphonyl, alkylsulphenyl, triazolyl, imidazolyl, tetrazolyl, hydrazido, alkylimidazolyl, thiazolyl, alkylthiazolyl, alkyloxazolyl, oxazolyl, alkylsulphonamido, alkylaminosulphonyl, aminosulphonyl, haloalkoxy, haloalkyl, a group of the formula —C(X 3 )N(R 11 )R 12  (wherein X 3  is O or S; and R 11  and R 12  are independently selected from hydrogen, methyl or ethyl or together with the nitrogen atom to which they are attached form a pyrrolidin-1-yl, piperidin-1-yl or morpholino group), or —OCH 2 O— which is bonded to two adjacent ring atoms in Cy;  
 X i  is a bond, O, NH or CH 2 ;  
 R 3i  is phenyl, pyridyl or pyrimidinyl optionally substituted by R 3a ;  
 R 1b , R 1c  and R 1j  are as defined for R 1a ;  
 L is CO;  
 and -Lp(D) n  is of the formula:  
                     
 wherein:  
 q is 1;  
 Q is —O— or —NH—;  
 and R q  is R c  which is pyridyl, pyrimidin-4-yl, pyridazin-3-yl, pyridazin-4-yl or phenyl (which phenyl or pyridyl group may bear a fluoro, chloro, alkyl, CONH 2 , SO 2 NH 2 , dialkylaminosulphonyl, methoxy, methylthio, alkylsulphonyl, alkylaminosulphonyl, alkylaminocarbonyl, amino, alkoxycarbonyl, acetylamino, cyano, ethoxy, nitro, hydroxy, alkylsulphonylamino, triazolyl or tetrazolyl substituent);  
 or a physiologically-tolerable salt thereof.  
 
     
     
         2 . A serine protease inhibitor compound according to  claim 1   
       wherein: 
 R 2  is a 5 or 6 membered aromatic carbon ring optionally interrupted by a nitrogen, oxygen or sulphur ring atom, optionally being substituted in the 3 and/or 4 position (in relation to the point of attachment of X—X) by halo, nitro, thiol, haloalkoxy, hydrazido, alkylhydrazido, amino, cyano, haloalkyl, alkylthio, alkenyl, alkynyl, acylamino, tri or difluoromethoxy, carboxy, acyloxy, MeSO 2 — or R 1 , or the substituents at the 3 and 4 positions taken together form a fused ring which is a 5 or 6 membered carbocyclic or heterocyclic ring optionally substituted by halo, haloalkoxy, haloalkyl, cyano, nitro, amino, hydrazido, alkylthio, alkenyl, alkynyl or R 1j , and optionally substituted in the position alpha to the X—X group (i.e. 6 position for a six membered aromatic ring etc) by amino, hydroxy, halo, alkyl, carboxy, alkoxycarbonyl, cyano, amido, aminoalkyl, alkoxy or alkylthio with the proviso that R 2  cannot be aminoisoquinolyl;  
 each X independently is a C, N, O or S atom or a CO, CR 1a , C(R 1a ) 2  or NR 1a  group, at least one X being C, CO, CR 1a  or C(R 1a ) 2 ;  
 each R 1a  independently represents hydrogen, hydroxyl, alkoxy, alkyl, aminoalkyl, hydroxyalkyl, alkoxyalkyl, alkoxycarbonyl, alkylaminocarbonyl, alkoxycarbonylamino, acyloxymethoxycarbonyl or alkylamino optionally substituted by hydroxy, alkylamino, alkoxy, oxo, aryl or cycloalkyl;  
 R 1  is as defined for R 1a , provided that R 1  is not unsubstituted aminoalkyl;  
 Y (the α-atom) is a nitrogen atom or a CR 1b  group;  
 Cy is a saturated or unsaturated, mono or poly cyclic, homo or heterocyclic group, preferably containing 5 to 10 ring atoms and optionally substituted by groups R 3a  or phenyl optionally substituted by R 3a ;  
 each R 3a  independently is R 1c , amino, halo, cyano, nitro, thiol, alkylthio, alkylsulphonyl, alkylsulphenyl, triazolyl, imidazolyl, tetrazolyl, hydrazido, alkyl imidazolyl, thiazolyl, alkyl thiazolyl, alkyl oxazolyl, oxazolyl, alkylsulphonamido, alkylaminosulphonyl, aminosulphonyl, haloalkoxy and haloalkyl;  
 R 1b , R 1c  and R 1j  are as defined for R 1a ;  
 L is CO;  
 and -Lp(D) n  is of the formula:  
                     
 wherein:  
 q is 1;  
 Q is —O— or —NH—;  
 and R q  is R c  which is pyridyl or phenyl (which phenyl may bear a fluoro, chloro, methyl, CONH 2 , SO 2 NH 2 , methylaminosulphonyl, dimethylaminosulphonyl, methylsulphonylamino, methoxy or methylsulphonyl substituent);  
 or a physiologically-tolerable salt thereof.  
 
     
     
         3 . (canceled)  
     
     
         4 . A compound according to  claim 2  wherein -Lp(D)n is selected from the following formulae:  
       
         
           
           
               
               
           
         
       
       wherein: 
 m represents 0; and  
 when R 3  is present as a substituent on an aromatic ring, it is selected from hydrogen, alkylsulphonyl, aminosulphonyl, alkylaminosulphonyl, alkylaminocarbonyl, amino, amido, alkoxycarbonyl, acetylamino, chloro, fluoro, cyano, methoxy, ethoxy, nitro, hydroxy, alkylsulphonylamino, triazolyl and tetrazolyl.  
 
     
     
         5 . (canceled)  
     
     
         6 . A compound according to any one of  claims 1  to  5  wherein Q is —NH—.  
     
     
         7 . A compound according to  claim 1  wherein Rc is pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimid-4-yl or phenyl.  
     
     
         8 . A compound according to  claim 1  any of  claims 1  to  3  wherein R c  is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2-methylsulfonylphenyl, 2-methylthiophenyl, pyrid-2-yl, pyrid-3-yl or pyrid-4-yl.  
     
     
         9 . A compound according to  claim 1  wherein R 2  is phenyl, thien-2-yl, naphthyl, indol-2-yl, indol-6-yl, benzo[b]furan-5-yl, -benzo[b]thiophen-2-yl or benzimidazol-2-yl (each of which is optionally substituted as defined in  claim 1) .  
     
     
         10 . A compound according to  claim 1  wherein optional substituents for R 2  are selected from: 
 fluoro, chloro, bromo, iodo, nitro, thiol, difluoromethoxy, trifluoromethoxy, hydrazido, methylhydrazido, amino, cyano, trifluoromethyl, methylthio, vinyl, ethynyl, acetylamino, carboxy, acetoxy, hydroxy, methyl, ethyl, amido (CONH 2 ), aminomethyl, methoxy and ethoxy.  
 
     
     
         11 . A compound according to  claim 1  wherein R 2  is selected from one of the formula (A′) to (H′):  
       
         
           
           
               
               
           
         
         wherein X 4  is O or S, R 13  is selected from hydrogen, chloro or methyl and R 14  is selected from hydrogen, methyl, ethyl, fluoro, chloro, and methoxy and R 15  is selected from hydrogen, methyl, fluoro, chloro and amino.  
       
     
     
         12 . A compound according to  claim 11 , wherein R 2  is 4-methoxyphenyl, 5-chloroindol-2-yl, 3-chloroindol-6-yl, indol-6-yl or 3-methylindol-6-yl.  
     
     
         13 . A compound according to  claim 1  wherein —X—X— is —CONH—.  
     
     
         14 . A compound according to any one of claims  1 ,  2 ,  4  and  7  to  13  wherein Y is CH.  
     
     
         15 . A compound according to  claim 1  wherein Cy is an optionally R 3a  substituted: phenyl, pyridyl, thienyl, thiazolyl, naphthyl, piperidinyl, furanyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, imidazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, pyrimidinyl, pyridazinyl, quinolyl, isoquinolyl, benzofuryl, benzothienyl or cycloalkyl group, or a phenyl group substituted by R 3i X i  in which X i  is a bond, O, NH or CH 2  and R 3i  is phenyl or pyridyl optionally substituted by R 3a .  
     
     
         16 . A compound according to  claim 2 , wherein Cy is an optionally R 3a  substituted: phenyl, pyridyl, thienyl, thiazolyl, naphthyl, piperidinyl or cycloalkyl group.  
     
     
         17 . (canceled)  
     
     
         18 . (canceled)  
     
     
         19 . A compound according to  claim 1  wherein R 3a  is selected from hydrogen, hydroxyl, methoxy, ethoxy, methyl, ethyl, methylaminomethyl, dimethylaminomethyl, hydroxymethyl, carboxy, methoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, aminomethyl, CONH 2 , CH 2 CONH 2 , acetylamino, methoxycarbonylamino, ethoxycarbonylamino, t-butoxycarbonylamino, amino, fluoro, chloro, bromo, cyano, nitro, thiol, methylthio, methylsulphonyl, ethylsulphonyl, methylsulphenyl, methylsulphonylamido, ethylsulphonylamido, methylaminosulphonyl, ethylaminosulphonyl, aminosulphonyl, trifluoromethoxy, trifluoromethyl, bromo, pyrrolidin-1-ylcarbonyl, piperidin-1-ylcarbonyl, morpholin-1-ylcarbonyl and —OCH 2 O— (which is bonded to two adjacent ring atoms in Cy).  
     
     
         20 . A compound according to  claim 2 , wherein R 3a  is selected from hydrogen, hydroxyl, methoxy, ethoxy, methyl, ethyl, methylaminomethyl, dimethylaminomethyl, hydroxymethyl, carboxy, methoxymethyl, methoxycarbonyl, ethoxycarbonyl, methylaminocarbonyl, dimethylaminocarbonyl, aminomethyl, CONH 2 , CH 2 CONH 2 , acetylamino, methoxycarbonylamino, ethoxycarbonylamino, t-butoxycarbonylamino, amino, fluoro, chloro, cyano, nitro, thiol, methylthio, methylsulphonyl, ethylsulphonyl, methylsulphenyl, methylsulphonylamido, ethylsulphonylamido, methylaminosulphonyl, ethylaminosulphonyl, aminosulphonyl, trifluoromethoxy and trifluoromethyl.  
     
     
         21 . A compound according to  claim 1 , wherein Cy is selected from:  
       
         
           
           
               
               
           
         
       
       wherein: 
 X′ is selected from O, S and NMe;  
 X″ is selected from O and S;  
 X′″ is selected from O, S, NH and NMe;  
 Y′ is selected from hydrogen, amino and methyl;  
 R o  is selected from hydrogen, methyl, fluoro, chloro, trifluoromethyl, methoxy, methylthio, methylsulphinyl and methylsulphonyl;  
 R m  is selected from hydrogen, methyl, fluoro, chloro, trifluoromethyl, methoxy, methylthio, methylsulphinyl, methylsulphonyl, carboxy, methoxycarbonyl and a group of the formula —C(X 3 )N(R 11 )R 12  (wherein X 3  is O or S, and R 11  and R 12  are independently selected from hydrogen, methyl or ethyl or together with the nitrogen atom to which they are attached form a pyrrolidin-1-yl, piperidin-1-yl or morpholino group);  
 R p  is selected from hydrogen and fluoro; or  
 R o  and R m  or R m  and R p  form an [[—OCH2O—]]—OCH 2 O— group; or  
 R o  and R m  together with the ring to which they are attached form a 5 or 6 membered aryl or heteroaryl ring (wherein the heteroary ring contains 1 or 2 heteroatoms selected from nitrogen, oxygen and sulfur); and  
 one of R o1  and R o2  is hydrogen and the other is R o .  
 
     
     
         22 . A compound according to  claim 1  wherein Cy is selected from phenyl, 2-chlorophenyl, 2-methoxyphenyl, 4-carbamoylphenyl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, imidazol-2-yl, thiazol-2-yl, thiazol-4-yl, 2-amino-thiazol-4-yl, thiazol-5-yl, naph-1-thyl, isoquinolin-5-yl, isoquinolin-8-yl, quinolin-4-yl, quinolin-5-yl and quinolin-8-yl.  
     
     
         23 . (canceled)  
     
     
         24 . A compound as claimed in  claim 14 , in which the alpha atom in Y is carbon and has the conformation that would result from construction from a D-α-aminoacid NH 2 —CR 1b (Cy)-COOH where the NH 2  represents part of X—X.  
     
     
         25 . A pharmaceutical composition, which comprises a compound as claimed in  claim 1  together with at least one pharmaceutically acceptable carrier or excipient.  
     
     
         26 . (canceled)  
     
     
         27 . (canceled)  
     
     
         28 . (canceled)  
     
     
         29 . A method of treatment of the human or non-human animal body to combat a thrombotic disorder, said method comprising administering to said body an effective amount of a compound according to  claim 1 .  
     
     
         30 . (canceled)  
     
     
         31 . A compound as claimed in  claim 1 , in which 
 R 2  is selected from one of the formula (A′) to (H′):                           wherein X 4  is O or S, R 13  is selected from hydrogen, chloro or methyl and R 14  is selected from hydrogen, methyl, ethyl, fluoro, chloro, and methoxy and R 15  is selected from hydrogen, methyl, fluoro, chloro and amino;    —X—X— is —CONH—;    Y is CH and has the conformation that would result from construction from a D-α-aminoacid NH 2 —CH(Cy)-COOH where the NH 2  represents part of X—X; and    Cy is selected from:                           wherein:    X′ is selected from O, S and NMe;    X″ is selected from O and S;    X′″ is selected from O, S, NH and NMe;    Y′ is selected from hydrogen, amino and methyl;    R o  is selected from hydrogen, methyl, fluoro, chloro, trifluoromethyl, methoxy, methylthio, methylsulphinyl and methylsulphonyl;    R m  is selected from hydrogen, methyl, fluoro, chloro, trifluoromethyl, methoxy, methylthio, methylsulphinyl, methylsulphonyl, carboxy, methoxycarbonyl and a group of the formula —C(X 3 )N(R 11 )R 12  (wherein X 3  is O or S, and R 11  and R 12  are independently selected from hydrogen, methyl or ethyl or together with the nitrogen atom to which they are attached form a pyrrolidin-1-yl, piperidin-1-yl or morpholino group);    R p  is selected from hydrogen and fluoro; or    R o  and R m  or R m  and R p  form an —OCH 2 O— group; or    R o  and R m  together with the ring to which they are attached form a 5 or 6 membered aryl or heteroaryl ring (wherein the heteroary ring contains 1 or 2 heteroatoms selected from nitrogen, oxygen and sulfur); and    one of R o1  and R o2  is hydrogen and the other is R o .    
     
     
         32 . A compound according to  claim 31 , in which 
 R 2  is 4-methoxyphenyl, 5-chloroindol-2-yl, 3-chloroindol-6-yl, indol-6-yl or 3-methylindol-6-yl;    Cy is selected from phenyl, 2-chlorophenyl, 2-methoxyphenyl, 4-carbamoylphenyl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, imidazol-2-yl, thiazol-2-yl, thiazol-4-yl, 2-amino-thiazol-4-yl, thiazol-5-yl, naph-1-thyl, isoquinolin-5-yl, isoquinolin-8-yl, quinolin-4-yl, quinolin-5-yl and quinolin-8-yl; and    Rc is phenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 3-methoxyphenyl, 4-methoxyphenyl, 2-methylsulfonylphenyl, 2-methylthiophenyl, pyrid-2-yl, pyrid-3-yl or pyrid-4-yl.    
     
     
         33 . A compound according to  claim 2 , in which 
 R 2  represents:    (i) phenyl optionally being substituted in the 3 and/or 4 position by fluoro, chloro, bromo, iodo, nitro, difluoromethoxy, trifluoromethoxy, amino, cyano, trifluoromethyl, methylthio, vinyl, carboxy, acetoxy, MeSO 2 —, hydroxy, methoxy, ethoxy, methyl, methoxycarbonyl, methylamino, ethylamino or amido, and optionally substituted at the 6 position by amino, hydroxy, fluoro, methoxycarbonyl, cyano or aminomethyl;    (ii) naphth-2-yl optionally substituted at the 6, position by hydroxy and optionally substituted at the 3 position by amino or hydroxy;    (iii) isoquinolin-7-yl, indol-5-yl, indol-6-yl, indazol-5-yl, indazol-6-yl, benzothiazol-6-yl or benzisoxazol-5-yl optionally substituted at the 3 position by chloro, bromo, amino, methyl or methoxy;    (iv) benzimidazol-5-yl or benzothiazol-6-yl optionally substituted at the 2 position by amino;    (v) thien-2-yl or thien-3-yl optionally substituted at the 4 or 5 position by methylthio, methyl or acetyl;    (vi) 3,4-methylenedioxyphenyl, 2,3-dihydroindol-6-yl, 3,3-dichloro-2-oxo-indol-6-yl or 1-methyl-3-aminoindazol-5-yl;    (vii) benzothiazol-2-yl, imidazo[1,2-a]pyrimidin-2-yl or tetrahydroimidazo[1,2-a]pyrimidin-2-yl;    (viii) pyrazol-2-yl substituted at the 5 position by methyl;    (ix) pyrid-2-yl optionally substituted at the 6 position by chloro;    (x) pyrid-3-yl optionally substituted at the 4 position by chloro;    (xi) benzofur-2-yl optionally substituted at the 3 position by chloro, methyl or methoxy, at the 5 or 6 position by methyl and at the 6 position by methoxy;    (xii) indol-2-yl optionally substituted on the indole nitrogen atom by methyl and optionally substituted at the 5 or 6 position by fluoro, chloro, bromo, methyl or methoxy;    (xiii) indol-6-yl substituted at the 5 position by chloro, fluoro or hydroxy and optionally substituted at the 3 position by chloro or methyl; or    (xiv) benzo[b]thiophen-2-yl optionally substituted at the 3 position by fluoro, chloro or methyl, and optionally substituted at the 5 or 6 position by fluoro, chloro, methyl, hydroxy, or methoxy;    —X—X— is —CONH—;    Y is CH and has the conformation that would result from construction from a D-α-aminoacid NH 2 —CH(Cy)-COOH where the NH 2  represents part of X—X; and    Cy is selected from phenyl, 4-aminophenyl, 4-amidophenyl, 4-(N-methyl)amidophenyl, 4-(N,N-dimethyl)amidophenyl, 2-chlorophenyl, 2-methylphenyl, 2-fluorophenyl, 3-fluorophenyl, 4-fluorophenyl, 4-hydroxphenyl, 2-methoxyphenyl, 4-methoxyphenyl, 4-carboxyphenyl, 3-ethylsulphonylaminophenyl, thien-2-yl, thien-3-yl, thiazol-4-yl, thiazol-5-yl, 2-methylthiazol-4-yl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, piperidin-4-yl, 1-methylpiperidin-4-yl, cyclohexyl and naphth-1-yl.    
     
     
         34 . A compound according to  claim 33 , in which -Lp(D)n is selected from the following formulae:  
       
         
           
           
               
               
           
         
       
       wherein: 
 m represents 0; and  
 when R 3  is present as a substituent on an aromatic ring, it is selected from hydrogen, alkylsulphonyl, aminosulphonyl, alkylaminosulphonyl, alkylaminocarbonyl, amino, amido, alkoxycarbonyl, acetylamino, chloro, fluoro, cyano, methoxy, ethoxy, nitro, hydroxy, alkylsulphonylamino, triazolyl and tetrazolyl.